Q32 Bio

1 follower

‌

Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.

Industries

Headquarters

Employees

Links

Org chart

Jodie Morrison

Acting CEO

Jodie Morrison

Collapse

Shelia Violette

Co-Founder & Chief Scientific Officer

Jason Campagna

Chief Medical Officer

David Appugliese

SVP & Head of People

Maria Marzilli

EVP, Corporate Strategy & Program Operations

Bill Lundberg

Independent Director

Dessi McEntee, MS, DABT

Associate Director, Toxicology

Fei Liu

Director, Pharmacology

Hong Wu, MD, PhD, DABT

Vp, Head Of Translational, Clinical Pharm, & Nonclinical Dev

Isidora Tošić

New Product Planning Manager

Joel Scherer

Vice President, Clinical Development, Immunotherapeutics

Justin Rogers

Director, Quality Assurance

Reena Malik

Associate Director - Regulatory Affairs

Theresa Carbeau

Director, CMC

Eric Bell

Senior Vice President Finance And Controller

Teams

+10

Finance & Strategic Planning

13 members

+10

Scientific Research & Development

13 members

Leadership Team

5 members

Clinical Operations

4 members

Quality Assurance & Regulatory Affairs

3 members

Similar companies

PerkinElmer

8 followers

AbbVie

151 followers

InnerPlant

1 follower

Worldwide Clinical Trials

4 followers

Day One Biopharmaceuticals

1 follower

PMV Pharmaceuticals

1 follower

Applied Therapeutics

1 follower

Anthos Therapeutics

1 follower

BioAge

3 followers

Odyssey Therapeutics

2 followers

Kubit

4 followers

Discover companies